Community use of intravenous tissue plasminogen activator for acute stroke: results of the brain matters stroke management survey.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Stroke

• Publication date

  2001-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.STR.32.4.861PMID 11283383
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recommendations for the establishment of primary stroke centers. Brain Attack Coalition.

  2000cited by this paper
• Recommendations for the establishment of primary stroke centers

  2000cited by this paper
• State of the journal

  1999cited by this paper
• Acute stroke: delays to presentation and emergency department evaluation.

  1999cited by this paper
• Thrombolytic therapy for acute ischemic stroke: why the majority of patients remain ineligible for treatment.

  1999cited by this paper
• Thrombolysis for Stroke

  1998cited by this paper
• Rapid identification and treatment of acute stroke

  1998cited by this paper
• Should thrombolytic therapy be the first-line treatment for acute ischemic stroke? Thrombolysis--not a panacea for ischemic stroke.

  1997cited by this paper
• Should thrombolytic therapy be the first-line treatment for acute ischemic stroke? t-PA--the best current option for most patients.

  1997cited by this paper
• Thrombolysis for stroke.

  1996cited by this paper
• Quality of care for Medicare patients with acute myocardial infarction. A four-state pilot study from the Cooperative Cardiovascular Project.

  1995cited by this paper
• Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.

  1995cited by this paper
• Tissue plasminogen activator for acute ischemic stroke.

  1995cited by this paper
• Current emergency department management of stroke in Houston, Texas.

  1995cited by this paper

• Use of evidence in acute stroke decision-making: Implications for evidence-based medicine.

  2021cites this paper
• The Use of Fibrinolytic Therapy in Acute Ischemic Events

  2020cites this paper
• A Virtual Success: Evaluation of the Ontario Stroke Strategy

  2020cites this paper
• Developing the Ethnographic Study

  2020cites this paper
• Chinese neurologists’ perspective on intravenous thrombolysis for acute ischemic stroke

  2017cites this paper
• Review article: Why is there still a debate regarding the safety and efficacy of intravenous thrombolysis in the management of presumed acute ischaemic stroke? A systematic review and meta‐analysis

  2016cites this paper
• Baseline Predictors of Poor Outcome in Patients Too Good to Treat With Intravenous Thrombolysis

  2016cites this paper
• Finding the Right t-PA Dose for Asians with Acute Ischemic Stroke.

  2016cites this paper
• Gaps and hurdles deter against following stroke guidelines for thrombolytic therapy in Iran: exploring the problem.

  2015cites this paper
• Systems From the American Stroke Association's Task Force on the Development of Stroke Recommendations for the Establishment of Stroke Systems of Care : Recommendations

  2013cites this paper
• Medicolegal Considerations with Intravenous Tissue Plasminogen Activator in Stroke: A Systematic Review

  2013cites this paper
• Plasminogen Activator for Acute Ischemic Stroke Physician Knowledge of the Benefits, Risks, and Contraindications of Tissue

  2012cites this paper
• Medico-Legal Aspects of Using Tissue Plasminogen Activator in Acute Ischemic Stroke

  2011cites this paper
• The Status of Acute Stroke Care in Saudi Arabia: An Urgent Call for Action!

  2011cites this paper
• Behavioral Equipoise: A Way to Resolve Ethical Stalemates in Clinical Research

  2011cites this paper
• Factors related to prehospital delay in stroke

  2011cites this paper
• The Social Organization of Best Practice for Acute Stroke: An Institutional Ethnography

  2010cites this paper
• Utilidad de los biomarcadores plasmáticos en el diagnóstico, tratamiento y pronóstico de la enfermedad cerebrovascular aguda

  2010cites this paper
• Enhancing community delivery of tissue plasminogen activator in stroke through community-academic collaborative clinical knowledge translation.

  2009cites this paper
• Implementation of evidence into practice: Development of a tool to improve emergency nursing care of acute stroke

  2009cites this paper
• Controversies in Stroke

  2008cites this paper
• [Intravenous thrombolytic treatment in acute ischemic stroke: initial results in the Complejo Hospitalario Universitario de Albacete].

  2008cites this paper
• Past, present and future of alteplase for acute ischemic stroke

  2008cites this paper
• JANUARY 16 HIGHLIGHT AND COMMENTARY: SUBSPECIALIZATION WITHIN SOMATOSENSORY CORTEX

  2007cites this paper
• Hyperbaric Oxygen-Induced Attenuation of Hemorrhagic Transformation After Experimental Focal Transient Cerebral Ischemia

  2007cites this paper
• Qualitative data collection and analysis methods: the INSTINCT trial.

  2007cites this paper
• Aneurysmal frontal bone cyst

  2007cites this paper
• In-Hospital Stroke in a Statewide Stroke Registry

  2007cites this paper
• Slow progressive acceptance of intravenous thrombolysis for patients with stroke by rural primary care physicians.

  2007cites this paper
• Determining Intravenous rt-PA Eligibility in the Emergency Department

  2007cites this paper
• Development of Stroke Systems Recommendations From the American Stroke Association's Task Force on the Recommendations for the Establishment of Stroke Systems of Care:

  2007cites this paper
• Frequency and Predictors of Symptomatic Intracerebral Hemorrhage in Patients with Ischemic Stroke Treated with Recombinant Tissue Plasminogen Activator outside Clinical Trials

  2006cites this paper
• The Need for New Therapies for Acute Ischaemic Stroke

  2006cites this paper
• Intravenous thrombolysis in acute ischaemic stroke: from trial exclusion criteria to clinical contraindications. An international Delphi study

  2006cites this paper
• The use of intravenous recombinant tissue plasminogen activator in acute ischemic stroke.

  2005cites this paper
• Is thrombolytic therapy associated with increased mortality? Meta-analysis of randomized controlled trials.

  2005cites this paper
• Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems.

  2005cites this paper
• Alteplase and ischaemic stroke: have new reviews of old data helped?

  2005cites this paper
• A Description of Canadian and United States Physician Reimbursement for Thrombolytic Therapy Administration in Acute Ischemic Stroke

  2005cites this paper
• Intravenous thrombolysis for acute ischaemic stroke: from randomised clinical trials to daily practice

  2005cites this paper
• Houston Paramedic and Emergency Stroke Treatment and Outcomes Study (HoPSTO)

  2005cites this paper
• Thrombolysis for acute stroke: the incontrovertible, the controvertible, and the uncertain.

  2005cites this paper
• Acute Stroke Treatment in the Community: Improving Our Performance and Expanding Our Options

  2005cites this paper
• Tissue plasminogen activator use: evaluation and initial management of ischemic stroke from an Iowa hospital perspective.

  2005cites this paper
• Recommendations for the Establishment of Stroke Systems of Care: Recommendations From the American Stroke Association’s Task Force on the Development of Stroke Systems

  2005cites this paper
• Thrombolysis in Acute Ischaemic Stroke

  2005cites this paper
• Acute stroke treatment in the community: improving our performance and expanding our options.

  2005cites this paper
• [Factors affecting the arrival time of cerebrovascular disease patients at the emergency department of a Peruvian hospital].

  2004cites this paper
• Intravenous thrombolysis for acute ischemic stroke.

  2004influential citation
• Society for Academic Emergency Medicine (SAEM) Neurologic Emergencies Interest Group response to the SAEM Board position on optimizing care of the stroke patient.

  2004cites this paper
• Feasibility of acute thrombolytic therapy for stroke.

  2003cites this paper
• Scientific and Ethical Issues in the Use of Placebo and Active Controls in Clinical Trials

  2003cites this paper
• Stroke, dementia, and drug delivery.

  2003cites this paper
• Frequency of Thrombolytic Therapy in Patients With Acute Ischemic Stroke and the Risk of In-Hospital Mortality: The German Stroke Registers Study Group

  2003cites this paper
• Tissue Plasminogen Activator for Acute Ischemic Stroke in Clinical Practice: A Meta-Analysis of Safety Data

  2003cites this paper
• Management of Acute Ischemic Stroke

  2002cites this paper
• Assessment of regional acute stroke care.

  2002cites this paper
• Systemic thrombolytic therapy of acute ischemic stroke with rtPA

  2002cites this paper
• Ethics and consent to treat issues in acute stroke therapy.

  2002cites this paper
• Future trends.

  2002cites this paper
• Acute Stroke Care in Illinois: A Statewide Assessment of Diagnostic and Treatment Capabilities

  2002cites this paper
• Treatment With Tissue Plasminogen Activator and Inpatient Mortality Rates for Patients With Ischemic Stroke Treated in Community Hospitals

  2001cites this paper
• Physician knowledge of the benefits, risks, and contraindications of tissue plasminogen activator for acute ischemic stroke.

  2001cites this paper
• Re: Systematic Comparison of the Early Outcome of Angioplasty and Endarterectomy for Symptomatic Carotid Artery Disease

  2001cites this paper
• Re: characteristics, outcome, and care of stroke associated with atrial fibrillation in Europe.

  2001cites this paper
• Characteristics, Outcome, and Care of Stroke Associated With Atrial Fibrillation in Europe: Data From a Multicenter Multinational Hospital–Based Registry (The European Community Stroke Project)

  2001cites this paper
• Further randomized controlled trials of tissue plasminogen activator within 3 hours are required.

  2001cites this paper
• Safety and efficacy of intraarterial thrombolysis for perioperative stroke after cardiac operation.

  2001cites this paper